NCT04546542View on ClinicalTrials.gov

Hydroxychloroquine Blood Levels in Primary Sjögren Syndrome Patients

CompletedOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

February 22, 2024

Study Completion Date

February 22, 2024

Conditions
Sjogren's Syndrome
Interventions
OTHER

Parallel Assignment

We will evaluate 75 patients with pSS (Consenso Americano-europeu de 2002 / EULAR/ACR Classification Criteria, 2016) of both sexes at baseline and 6-months

Trial Locations (2)

05403-000

Rheumatology Division of Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo

Hospital das Clinicas da Faculdade de Medicina da USP, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT04546542 - Hydroxychloroquine Blood Levels in Primary Sjögren Syndrome Patients | Biotech Hunter | Biotech Hunter